(Q29547224)

English

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

scientific article (publication date: May 2009)

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

phase III clinical trial

0 references

adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

J Gregory Cairncross

23

object named as

Cairncross JG

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

author name string

Stupp R

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Hegi ME

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Mason WP

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

van den Bent MJ

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Taphoorn MJ

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Janzer RC

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Ludwin SK

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Allgeier A

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Fisher B

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Belanger K

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Hau P

11

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Brandes AA

12

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Gijtenbeek J

13

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Marosi C

14

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Vecht CJ

15

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Mokhtari K

16

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Wesseling P

17

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Villa S

18

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Eisenhauer E

19

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Gorlia T

20

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Weller M

21

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Lacombe D

22

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Mirimanoff RO

24

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

publication date

May 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Lancet Oncology Commission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

459-66

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in patients with glioblastoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel tool to analyze MRI recurrence patterns in glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of human glioma cells treated with various combination of temozolomide and X-rays

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary brain tumours in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

How not to treat cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of MGMT in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

MGMT: its role in cancer aetiology and cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy in malignant glioma: standard of care and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lessons learned in the development of targeted therapy for malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970025-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(09)70025-7

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19269895

23 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29547224&oldid=1953873726"